Home > Balance Sheet > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Balance Sheet

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Balance Sheet History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
EQUITY AND LIABILITIES
Share Capital ₹11 Cr₹11 Cr₹10 Cr₹10.00 Cr₹10.00 Cr
    Equity - Authorised ₹40 Cr₹40 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity - Issued ₹11 Cr₹11 Cr₹10 Cr₹10.00 Cr₹10.00 Cr
    Equity Paid Up ₹11 Cr₹11 Cr₹10 Cr₹10.00 Cr₹10.00 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹2.00₹10.00₹10.00₹10.00₹10.00
Share Warrants & Outstandings -₹3.77 Cr₹10 Cr--
Total Reserves ₹221 Cr₹187 Cr₹162 Cr₹103 Cr₹55 Cr
    Securities Premium ₹57 Cr₹51 Cr₹19 Cr₹11 Cr₹11 Cr
    Capital Reserves -----
    Profit & Loss Account Balance ₹163 Cr₹136 Cr₹143 Cr₹92 Cr₹44 Cr
    General Reserves ₹0.64 Cr₹0.05 Cr₹0.05 Cr₹0.05 Cr₹0.05 Cr
    Other Reserves -----
Reserve excluding Revaluation Reserve ₹221 Cr₹187 Cr₹162 Cr₹103 Cr₹55 Cr
Revaluation reserve -----
Shareholder's Funds ₹232 Cr₹201 Cr₹183 Cr₹113 Cr₹65 Cr
Minority Interest -----
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans ₹21 Cr-₹0.87 Cr--
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks -----
    Loans - Govt. -----
    Loans - Others -----
    Other Unsecured Loan ₹21 Cr-₹0.87 Cr--
Deferred Tax Assets / Liabilities ₹0.90 Cr₹1.00 Cr₹1.10 Cr₹0.04 Cr₹0.01 Cr
    Deferred Tax Assets ₹0.10 Cr₹0.11 Cr---
    Deferred Tax Liability ₹1.00 Cr₹1.10 Cr₹1.10 Cr₹0.04 Cr₹0.01 Cr
Other Long Term Liabilities ₹1.80 Cr₹1.74 Cr₹1.69 Cr--
Long Term Trade Payables -----
Long Term Provisions ₹0.13 Cr₹0.04 Cr---
Total Non-Current Liabilities ₹24 Cr₹2.78 Cr₹3.66 Cr₹0.04 Cr₹0.01 Cr
Current Liabilities -----
Trade Payables ₹16 Cr₹29 Cr₹35 Cr₹49 Cr₹25 Cr
    Sundry Creditors ₹16 Cr₹29 Cr₹35 Cr₹49 Cr₹25 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹4.61 Cr₹4.62 Cr₹2.81 Cr₹3.26 Cr₹0.14 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers -----
    Interest Accrued But Not Due -₹0.01 Cr---
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹4.61 Cr₹4.60 Cr₹2.81 Cr₹3.26 Cr₹0.14 Cr
Short Term Borrowings ₹30 Cr₹18 Cr₹11 Cr₹3.64 Cr₹3.66 Cr
    Secured ST Loans repayable on Demands ₹0.05 Cr₹2.93 Cr₹4.99 Cr₹2.64 Cr₹0.33 Cr
    Working Capital Loans- Sec ₹0.05 Cr₹2.78 Cr₹4.42 Cr--
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹30 Cr₹12 Cr₹1.34 Cr₹1.00 Cr₹3.33 Cr
Short Term Provisions ₹3.37 Cr₹2.88 Cr₹5.06 Cr₹7.25 Cr₹6.01 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹3.37 Cr₹2.88 Cr₹5.06 Cr₹7.25 Cr₹6.01 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions -----
Total Current Liabilities ₹55 Cr₹54 Cr₹53 Cr₹63 Cr₹35 Cr
Total Liabilities ₹310 Cr₹258 Cr₹240 Cr₹176 Cr₹100 Cr
ASSETS
Gross Block ₹43 Cr₹43 Cr₹44 Cr₹30 Cr₹2.75 Cr
Less: Accumulated Depreciation ₹1.90 Cr₹2.10 Cr₹2.35 Cr₹0.76 Cr₹0.30 Cr
Less: Impairment of Assets -----
Net Block ₹41 Cr₹41 Cr₹41 Cr₹29 Cr₹2.45 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹22 Cr₹2.31 Cr₹2.83 Cr₹0.57 Cr-
Non Current Investments ----₹3.42 Cr
Long Term Investment ----₹3.42 Cr
    Quoted -----
    Unquoted ----₹3.42 Cr
Long Term Loans & Advances ₹4.03 Cr₹4.58 Cr₹1.52 Cr₹1.27 Cr₹0.05 Cr
Other Non Current Assets ₹0.50 Cr₹0.40 Cr₹0.40 Cr₹4.87 Cr-
Total Non-Current Assets ₹68 Cr₹48 Cr₹46 Cr₹35 Cr₹5.91 Cr
Current Assets Loans & Advances -----
Currents Investments -----
    Quoted -----
    Unquoted -----
Inventories ₹78 Cr₹82 Cr₹105 Cr₹99 Cr₹14 Cr
    Raw Materials -----
    Work-in Progress -----
    Finished Goods -----
    Packing Materials -----
    Stores  and Spare -----
    Other Inventory ₹78 Cr₹82 Cr₹105 Cr₹99 Cr₹14 Cr
Sundry Debtors ₹111 Cr₹56 Cr₹52 Cr₹28 Cr₹77 Cr
    Debtors more than Six months ₹20 Cr₹10 Cr₹12 Cr₹13 Cr-
    Debtors Others ₹91 Cr₹45 Cr₹40 Cr₹15 Cr₹77 Cr
Cash and Bank ₹39 Cr₹62 Cr₹28 Cr₹7.19 Cr₹1.67 Cr
    Cash in hand ₹0.78 Cr₹1.79 Cr-₹0.62 Cr₹0.05 Cr
    Balances at Bank ₹39 Cr₹61 Cr₹28 Cr₹6.57 Cr₹1.62 Cr
    Other cash and bank balances -----
Other Current Assets ₹2.21 Cr₹2.02 Cr₹3.78 Cr₹3.90 Cr₹0.77 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹2.21 Cr₹2.02 Cr₹3.78 Cr₹3.12 Cr₹0.72 Cr
    Other current_assets ---₹0.78 Cr₹0.05 Cr
Short Term Loans and Advances ₹12 Cr₹7.99 Cr₹4.21 Cr₹3.65 Cr₹0.95 Cr
    Advances recoverable in cash or in kind ₹8.71 Cr₹6.42 Cr₹2.89 Cr₹2.37 Cr₹0.35 Cr
    Advance income tax and TDS ---₹0.78 Cr₹0.61 Cr
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹3.17 Cr₹1.58 Cr₹1.32 Cr₹0.50 Cr-
Total Current Assets ₹243 Cr₹210 Cr₹194 Cr₹141 Cr₹94 Cr
Net Current Assets (Including Current Investments) ₹188 Cr₹156 Cr₹140 Cr₹78 Cr₹59 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹310 Cr₹258 Cr₹240 Cr₹176 Cr₹100 Cr
Contingent Liabilities -----
Total Debt ₹52 Cr₹18 Cr₹12 Cr₹3.64 Cr₹3.66 Cr
Book Value -181.31169.51113.1664.98
Adjusted Book Value 41.9836.2633.9022.6313.00

Compare Balance Sheet of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹232.2 Cr -1.3% -5.2% -53.5% Stock Analytics
ADANI ENTERPRISES ₹292,562.0 Cr -2.2% -3.2% -12.1% Stock Analytics
REDINGTON ₹20,576.3 Cr -2.9% -2.7% 56.3% Stock Analytics
LLOYDS ENTERPRISES ₹10,603.4 Cr -5.4% 2.6% 57.8% Stock Analytics
MMTC ₹10,320.0 Cr -2.1% -2.1% -12.5% Stock Analytics
HONASA CONSUMER ₹9,105.5 Cr -2.8% -8% -32.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.3%

-5.2%

-53.5%

SENSEX

0.3%

3.6%

5.5%


You may also like the below Video Courses